We are live on
!
Find out more
JBIO
Jade Biosciences
JBIO
JBIO
120 hedge funds and large institutions have $734M invested in Jade Biosciences in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
123% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 13
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
18% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 33
14% more funds holding
Funds holding: 105 → 120 (+15)
8.46% more ownership
Funds ownership: 95.46% → 103.92% (+8.5%)
1% more capital invested
Capital invested by funds: $726M → $734M (+$8.21M)
87% less call options, than puts
Call options by funds: $163K | Put options by funds: $1.23M
Holders
120
Holders Change
+15
Holders Change %
+14.29%
% of All Funds
1.48%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.07%
New
29
Increased
39
Reduced
33
Closed
13
Calls
$163K
Puts
$1.23M
Net Calls
-$1.07M
Net Calls Change
+$684K
Top Buyers
Top Sellers
| 1 |
RI
RTW Investments
New York
|
-$12.7M |
| 2 |
BlackRock
New York
|
-$8.06M |
| 3 |
O
OrbiMed
New York
|
-$5.01M |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$4.58M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.26M |
